EUVIMEDEUVIMED entdecken
Crossref

HP1 enhances radio- and chemotherapy resistance in osteosarcoma via PARP1-dependent transcriptional repression and HR repair

Yuanxin Zhu, Wenjia Li, Yuntan Qiu, Zhihuai Deng, Yu Li, Hengxing Chen, Jingyuan Zhang, Daning Lu, Kaishun Hu, Dongsheng Huang, Dong Yin

Cancer Letters · 2026-02 · 639 · 218213

DOI: 10.1016/j.canlet.2025.218213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026-02. Verfasst von Yuanxin Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumour Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medic…. Hauptthemen laut MEDLINE: Osteosarcoma, Poly (ADP-Ribose) Polymerase-1, Bone Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Key Technologies Research and Development Program, Science and Technology Planning Project of Guangdong Province, Guangzhou Women and Childrens Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma is a primary malignant bone tumour with an unsatisfactory prognosis, and individualised and comprehensive treatment is needed. HP1 (α/β/γ) is an important heterochromatin protein involved in transcriptional regulation and is also involved in the DNA damage response (DDR). However, little is known about the participation of HP1 in DNA damage-induced transcriptional repression. In this study, HP1 proteins were shown to be involved in DNA damage-mediated transcriptional repression at the very onset of DNA damage. Mechanistically, HP1 proteins were recruited to DNA damage sites by interacting with and being covalently PARylated by PARP1. This process increased H2AK119Ub, which ultimately led to the inactivation of RNA Pol II to achieve transcriptional suppression. Silencing HP1 led to a weakening of PARP1 recruitment and homologous recombination (HR) repair. Concurrently, HP1γ (CBX3) knockdown resulted in an increased the sensitivity of osteosarcoma cells to radiotherapy, chemotherapy and PARP1 inhibitors. The results of the study demonstrated the involvement of HP1 in the DDR via covalent PARylation by PARP1, resulting in the suppression of transcription and the promotion of HR repair. Overall, these results identify a new molecular mechanism of DNA damage-induced transcriptional repression and provide a theoretical basis for the potential application of DNA damage-induced transcriptional repression in the treatment of osteosarcoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaPoly (ADP-Ribose) Polymerase-1Bone NeoplasmsDrug Resistance, NeoplasmChromosomal Proteins, Non-HistoneRadiation ToleranceRecombinational DNA RepairHumansCell Line, TumorChromobox Protein Homolog 5DNA DamageTranscription, GeneticGene Expression Regulation, NeoplasticPoly(ADP-ribose) Polymerase Inhibitors

Stichwörter der Autor:innen

DNA damage responseHP1OsteosarcomaPARP1

Substanzen

Poly (ADP-Ribose) Polymerase-1PARP1 protein, humanChromosomal Proteins, Non-HistoneChromobox Protein Homolog 5Poly(ADP-ribose) Polymerase Inhibitors

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumour Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen Univers…
  • Department of Pathology, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, China.
  • Department of Orthopedics, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, 510120, China.
  • Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
  • Department of Orthopedics, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, 510120, China. Electronic address: hdongsh@mail.sysu.edu.cn.

Förderung

  • Key Technologies Research and Development Program
  • Science and Technology Planning Project of Guangdong Province
  • Guangzhou Women and Childrens Medical Center
  • Tip-top Scientific and Technical Innovative Youth Talents of Guangdong Special Support Program
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Zhu, Y., Li, W., Qiu, Y., Deng, Z., Li, Y., Chen, H., Zhang, J., Lu, D., Hu, K., Huang, D., & Yin, D. (2026). HP1 enhances radio- and chemotherapy resistance in osteosarcoma via PARP1-dependent transcriptional repression and HR repair. Cancer Letters, 639, 218213. https://doi.org/10.1016/j.canlet.2025.218213

Vancouver

Zhu Y, Li W, Qiu Y, Deng Z, Li Y, Chen H, et al. HP1 enhances radio- and chemotherapy resistance in osteosarcoma via PARP1-dependent transcriptional repression and HR repair. Cancer Letters. 2026;639:218213. doi:10.1016/j.canlet.2025.218213

BibTeX
@article{Zhu2026,
  author = {Zhu, Yuanxin and Li, Wenjia and Qiu, Yuntan and Deng, Zhihuai and Li, Yu and Chen, Hengxing and Zhang, Jingyuan and Lu, Daning and Hu, Kaishun and Huang, Dongsheng and Yin, Dong},
  title = {HP1 enhances radio- and chemotherapy resistance in osteosarcoma via PARP1-dependent transcriptional repression and HR repair},
  journal = {Cancer Letters},
  year = {2026},
  volume = {639},
  pages = {218213},
  doi = {10.1016/j.canlet.2025.218213}
}
Kostenlos starten →